Status:
UNKNOWN
Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease
Lead Sponsor:
Fondazione del Piemonte per l'Oncologia
Conditions:
Solid Tumors
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to define the molecular profile of selected solid tumors. From each participants will be collected biological materials for molecular analysis, including saliva, bloo...
Eligibility Criteria
Inclusion
- Patients with at least one of the following selected solid tumors:
- Colorectal Cancer (primary or with synchronous/metachronous liver metastases)
- Prostate Cancer
- Head \& Neck Tumors
- Gastric Cancer
- Glioblastoma
- Breast Cancer
- Hepatocarcinoma
- Biliary Tract Carcinoma
- Lung Cancer (primary)
- Rare Tumors (incidence ≤ 5x10-6)
- Metastatic Sarcoma
- Metastatic Melanoma
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT03347318
Start Date
January 1 2011
End Date
December 1 2021
Last Update
November 20 2017
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Regionale Umberto Parini
Aosta, Italy
2
Policlinico S.Orsola Malpighi
Bologna, Italy
3
Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia (FPO-Irccs)
Candiolo, Italy
4
Azienda Ospedaliero-Universitaria Careggi
Genova, Italy